Ace the Case: Disease Progression in a 72-Year-Old Woman With Chronic Lymphocytic Leukemia Previously Treated With Venetoclax-Obinutuzumab

This activity utilizes a case study to discuss treatment options for an older patient with relapsed chronic lymphocytic leukemia (CLL).
Postgraduate Institute for Medicine

Nursing Management of Cancer Treatment-Induced Cardiotoxicity

Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of cancer teatment-induced cardiotoxicity. STATEMENT OF NEED Several studies reveal that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. Adverse cardiac effects may occur immediately after cessation of therapy or, in som...
i3 Health

Prurigo Nodularis: A Caucasian Adult Male With History of Uncontrolled PN and Associated Comorbidities

Target Audience The target audience will be comprised of dermatologists, specialty nurse practitioners, specialty physician assistants, and managed care pharmacists. Program Overview Prurigo nodularis (PN) is a chronic condition mediated by immune and neural dysregulation and presenting with highly pruritic, hyperkeratotic papules or nodules; the condition disproportionately affects African American patients compared to the general population. There are currently no FDA-approved thera...
AKH Inc., Advancing Knowledge in Healthcare and Spire Learning

Prurigo Nodularis: An Older African American Female Adult Presenting With Nodular Lesions and Persistent Itching

Target Audience The target audience will be comprised of dermatologists, specialty nurse practitioners, specialty physician assistants, and managed care pharmacists. Program Overview Prurigo nodularis (PN) is a chronic condition mediated by immune and neural dysregulation and presenting with highly pruritic, hyperkeratotic papules or nodules; the condition disproportionately affects African American patients compared to the general population. There are currently no FDA-approved thera...
AKH Inc., Advancing Knowledge in Healthcare and Spire Learning.

Making A Difference for Your AD Patients: Patient-Centric Strategies to Improve Their Care - Adult Case

Target Audience Dermatologists, allergists, immunologists, other specialists (MD/DOs), and nurse practitioners, physician assistants. Program Overview This engaging and clinically relevant learning design system will improve your skills in assessing and treating patients with atopic dermatitis and establish the importance of personalized and individualized care to optimize outcomes. Learning Objectives Upon completion of this activity, participants should be better able to: D...
Horizon CME

Do It Better: Case Studies in Screening for Diabetic Retinopathy for Primary Care

Target Audience This activity is intended for health care professionals involved with the management or treatment of patients with type 2 diabetes. Program Overview These activities explain the pathophysiology of diabetic retinopathy/diabetic macular edema, the importance of early screening, and the therapeutic treatment options including VEGF inhibitor. Learning Objectives Upon completion of this activity, participants should be better able to: Use retinal screening devices,...
Postgraduate Institute for Medicine and DKBmed, LLC

Treatment Advances in Waldenstrom Macroglobulinemia

In this case-based discussion, Morie Gertz, MD, Chair of General Internal Medicine at the Mayo Clinic in Minnesota, will discuss how to use predictive and prognostic markers to select treatment for patients with Waldenstrom macroglobulinemia (WM) and how to appraise emerging clinical trial data and adverse event management strategies for novel treatments. Start the activity now. STATEMENT OF NEED Waldenstrom macroglobulinemia (WM) is a rare cancer of B lymphocytes associated with lymphop...
i3 Health

Updates in Mantle Cell Lymphoma

Discover insights on predictive and prognostic markers, emerging efficacy and safety data, strategies to optimize tolerability for patients receiving novel therapies for mantle cell lymphoma (MCL), and more in this case-based activity presented by John Leonard, MD, the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology at Weill Cornell Medicine. Start the activity now. STATEMENT OF NEED Mantle cell lymphoma (MCL) is an aggressive variant of B-cell non-Hodgkin ly...
i3 Health

Case Study Challenges for Better Identification of DR in Primary Care

Target Audience This activity is intended for primary care clinicians and allied health providers who treat patients with type 2 diabetes. Learning Objectives After completing this activity, the participant should be better able to: Explain the pathophysiology of diabetic retinopathy/diabetic macular edema, the importance of early screening, and the therapeutic treatment options including VEGF inhibitors Describe and use available retina screening devices with and without AI to en...
Postgraduate Institute for Medicine and DKBmed, LLC

Navigating Advances in Alport Syndrome: Enhancing Diagnosis and Optimizing Outcomes

Target Audience This activity is designed to meet the educational needs of nephrologists, ophthalmologists, audiologists, and allied healthcare professionals who during their practice may treat and/or manage patients with Alport syndrome. Program Overview Alport syndrome, also known as hereditary nephritis, is a rare genetic disorder characterized by progressive kidney disease and abnormalities of the inner ear and the eye, affecting 30,000 to 60,000 patients in the US alone accountin...
Excel Continuing Education

Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care

Target Audience This educational activity is directed toward hematologists, cardiologists, pulmonologists, neurologists, primary care physicians, and advanced care providers who work with patients with sickle cell disease. Learning Objectives Upon successful completion of this activity, you should be better prepared to: • Identify key features of acute vaso-occlusive pain in patients with SCD • Describe the associated complications from SCD-related acute pain episodes • Implement...
Physicians’ Education Resource®, LLC

Community Practice Connections: DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We, and Where Are We Going?

Target Audience This educational program is directed toward medical oncologists, hematologists, and other health care professionals who treat patients with MPNs. Fellows, researchers, nurse practitioners, nurses, physician assistants, and other allied professionals interested in hematologic malignancies are also invited to attend. Learning Objectives Upon successful completion of this activity, you should be better prepared to: • Determine the impact of genetics, symptom burden, and ri...
Physicians’ Education Resource®, LLC

Community Practice Connections™: Cold Agglutinin Disease: Shifting the Treatment Paradigm Through Improved Understanding of the Complement System

Target Audience The target audience for this activity is hematologists and hematologist-oncologists. Pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with CAD are also invited to attend.The target audience for this activity is hematologists and hematologist-oncologists. Pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with CAD are also inv...
Physicians’ Education Resource®, LLC.

Optimizing Management of Iron Overload: Strategies to Improve Identification and Treatment

Target Audience This educational program will be directed toward hematologists, pediatricians, nurses, nurse practitioners, physician assistants, and other clinicians involved in the management of patients with iron overload. Program Overview This online, on-demand virtual symposium brings together renowned experts in hematology and iron overload. In this educational program, these experts provide an overview of the pathophysiology and burden of iron overload as well as guideline-base...
Physicians’ Education Resource®, LLC.

Examining the CV Safety of Fenfluramine for Dravet Syndrome

TARGET AUDIENCE The educational design of this activity addresses the needs of neurologists, pediatric neurologists, epileptologists, pediatric epileptologists, pediatricians, primary care providers, general practitioners, nurses, nurse practitioners, physician assistants, and pharmacists involved and/or interested in the management of patients with DS. STATEMENT OF NEED/PROGRAM OVERVIEW Data from recent randomized clinical trials have showed that fenfluramine is well tolerated and has ...
Global Education Group and PlatformQ Health Education, LLC

Matching Treatment to Mutations: Clinical Pathways to Optimize RET+ Testing in NSCLC and Thyroid Cancer

This recording from a series of expert-led small group meet-ups will increase your knowledge of RET inhibitors, help you gain confidence in utilizing biomarkers to inform treatment decisions, and improve collaboration between oncologists and pathologists to optimize precision medicine for RET-positive metastatic NSCLC and advanced thyroid cancer.
Penn State College of Medicine

Update CME: Internal Medicine and Primary Care LiveStream Rebroadcast June 2022

This conference (7.30 a.m. June 23 - 1.15 p.m. June 26) is organized by the American Medical Forum. Eminent speakers from The University of Chicago, Rush University, and Northwestern University will present the most advanced clinical guidelines. The course also offers live Q&A, and each speaker will take the time to answer your questions. At the conclusion, participants will be able to incorporate the most up-to-date treatment strategies to general chronic medical conditions implemented in rec...
American Medical Forum

Modernizing Care of Patients With BCC: Changes in Management Approaches

Utilize an interdisciplinary approach to identify patients with advanced BCC and apply expert guidance and clinical guidelines to determine the best treatment pathway for individual patients. Identify patients with advanced BCC who have failed or cannot tolerate hedgehog inhibitor therapy and utilize an interdisciplinary approach to assess treatment options, including PD-1 inhibitors, and develop a plan to prevent/manage treatment-associated adverse events.
Evolve Medical Education LLC

Diabetes Update 2022 - LIVE STREAMING

This highly rated Harvard Medical School CME course offers practical strategies to address the medical and systemic challenges to optimal care and updates that ensure you can deliver state-of-the-art care for your patients with diabetes. PROGRAM HIGHLIGHTS This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care. • Expert guidance to design comprehensive treat...
Harvard Medical School

41st Annual Cardiothoracic Surgery Symposium (CREF 2022)

The 41st Annual Cardiothoracic Surgery Symposium (CREF 2022) offers cutting-edge presentations, interactive discussions and debates, hands-on workshops, and extracurricular education on topics related to cardiac surgery, cardiopulmonary bypass, extracorporeal perfusion, and extracorporeal life support. It offers Category 1 CME & CEU credits, meeting the specific educational needs of CVOR and CVICU teams: cardiac anesthesiologists, cardiac surgeons, advanced-practice providers, nurses, and perf...
Cardiothoracic Research and Education Forum

Patient, Provider, and Caregiver Connection™: Limiting the Patient Burden of Neurotrophic Keratitis Non-COPE

Target Audience This online educational activity is directed towards general ophthalmologists and optometrists. Additional clinicians who may have the opportunity to diagnosis patients with neurotrophic keratitis will also be invited to participate. Activity Overview This video-based program is designed for health care professionals to explore the diagnosis and treatment of neurotropic keratitis (NK) through a unique perspective, putting the patient voice front and center. A patient w...
Physicians’ Education Resource®, LLC.

Advances in™ Dry Eye Disease - The Future of Treatment for Patients with Meibomian Gland Dysfunction-Associated DED

Target Audience This online educational activity is directed toward ophthalmologists, optometrists and other healthcare professionals who would be involved in dry eye disease care, such as PCPs, NPs and PAs. Program Overview This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of meibomian gland dysfunction (MGD)-associated dry eye disease (DED), with a forward-looking perspective on how new and novel agents may impact...
Physicians’ Education Resource®, LLC.

Real-World Experience in Diagnosing and Managing PNH in Special Patient Populations

In a “how I do it” clinical commentary, Dr. Jamile Shammo and Dr. Ilene Weitz share their real-world experience in the diagnosis and management of PNH in special patient populations. This case-based activity includes clinical scenarios and treatment strategies to improve patient outcomes.
ACHL

Answering the Call: Nurse-Led Strategies to Improve Compliance with Hemophilia Prophylaxis

Prophylactic management of hemophilia continues to be a challenge. The nurse-led activity discusses treatment strategies, safety and efficacy of current available products, and how to improve patient adherence. In this clinical commentary Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C review best practices to facilitate successful therapeutic interventions with hemophilia A Kerry H. Hansen, RN, BS and Skye Peltier, MPH, PA-C
ACHL

Respiratory Syncytial Virus: Protecting Older Adults at Risk for Serious Complications

Target Audience This activity was developed for family practice physicians, primary care physicians, nurse practitioners, nurses and other healthcare professionals who care for older adults. Program Overview Each year, respiratory syncytial virus (RSV) infects up to 10% of older adults who live in congregate settings and predisposes to an increased risk for hospitalization and death, particularly in those with comorbid cardiopulmonary disease. Stefan Gravenstein, MD, MPH, compares the...
The Annenberg Center for Health Sciences at Eisenhower

Continuity in Care®: Best Practices in Immunoglobulin Therapy—Improving Quality of Life for Patients With Primary Immunodeficiency

Target Audience These activities are intended for an audience of immunologists, infusion nurses, pediatricians, nurse practitioners, physician assistants, and pharmacists involved in the dispensing and administration of immunoglobulin replacement therapy (IgG) for patients with PI. Program Overview This video-based program is designed to help health care professionals explore treatment options for patients with primary immunodeficiency (PI) through a unique perspective: putting the pa...
Physicians’ Education Resource®, LLC.

Neurology in Clinical Practice

The Neurology in Clinical Practice conference is an annual Mayo Neurology course that brings together a multidisciplinary faculty from across our three campuses in Rochester, MN; Jacksonville, FL; and Scottsdale, AZ. The course format consists of case-based presentations in the morning and is reinforced with optional afternoon workshops. This program will explore common neurology clinical problems and is intended to provide a comprehensive, evidence-based review of recent advances in the evalu...
Mayo Clinic

PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies

Target Audience This educational activity is directed toward community neurologists, neuroimmunologists, MS specialists, specialty nurse practitioners, physician assistants, registered nurses, pharmacists, and other members of the MS care team. Activity Overview The COVID-19 pandemic is an unprecedented health care crisis with disproportionate impact on immunocompromised populations. There are unanswered questions and a lack of understanding about the immune response to SARS-CoV-2 vaccine...
Relias LLC

Medical Crossfire®: Personalized Regimens for Managing Hemophilia A: Selecting an Optimal Recombinant FVIII Agent

Target Audience This online educational activity is directed toward hematologists, primary care clinicians, nurse practitioners, physician assistants, nurses, and other health care professionals who are involved in the management of hemophilia. Activity Overview Over the past 20 years, substantial advances in the treatment of hemophilia A have allowed patients to take greater control of their disease. The primary goals of hemophilia A treatment are to prevent bleeding episodes, reduce lon...
Relias LLC

Improving Selection and Utilization of Continuous Glucose Monitors (CGM) for People with Diabetes

Self-monitoring of blood glucose (BG) levels is critical to daily self-management for people with diabetes. Studies have shown that intensive insulin regimens and BG control corresponded with better glycemic control have resulted in a significant decrease in the microvascular complications of diabetes. Because CGM is still an evolving technology, both clinicians and patients would benefit from engaging, interactive, and evidence-based education to improve the utilization of these tools. 
Dannemiller

Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment

Target Audience This activity is designed to meet the educational needs of neurologists, nursing professionals, PAs, pharmacists, and other healthcare professionals involved in the management of patients with neuromyelitis optica spectrum disorder (NMOSD). Program Overview The enduring activity is designed to provide evidence-based education on the diagnosis of patients with NMOSD, evidence on novel treatments, and considerations in personalizing therapy. Learning Objectives Upon comp...
Relias LLC

Case Challenges in Patients With EGFR-Mutant NSCLC

This activity offers a case challenge of two patients with EGFR-mutant NSCLC, through which learners apply knowledge from the molecular testing guidelines and evidence from clinical trials as presented in the related activity, Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC. Learners work through patient cases during which they are questioned about how they would proceed at different clinical decision points. Expert clinical commentary includes recommendatio...
ACHL

Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC

This interactive digital activity combines animated slides and expert video commentary on molecular testing recommendations, guidance on interpreting molecular testing results, and clinical trial evidence to enhance the implementation of precision medicine in the care of patients with EGFR-mutant NSCLC. Through this education, learners explore best practices for EGFR mutation testing, application of clinical trial data to treatment selection, and the role of concurrent mutations in the prognos...
ACHL

A Next Generation of Pneumococcal Disease Protection

Target Audience This activity is intended for infectious disease specialists, primary care physicians, advanced practice providers, pharmacists, nurses and other clinicians who manage adult patients for whom pneumococcal vaccination is recommended. Program Overview In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert...
Relias LLC

A Next Generation of Pneumococcal Disease Protection

In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert insights on considerations for next generation pneumococcal vaccine use, patient access to these newer vaccines, and strategies for engaging patients. Two case studies drive home practical strategies to implement in day-to-day practice.
ACHL

Practical Guidance for the Community Oncologist — Incorporating Advances in Therapy for Metastatic TNBC: A Focus on TROP2

Are you involved in treating patients with triple negative breast cancer (TNBC)? The emergence of TROP2-directed antibody drug conjugate (ADC) technology has paved the way for exciting new targeted treatment approaches for patients with TNBC. What are the latest data with these ADCs? Why is TROP2 an effective target in TNBC? How do we best incorporate these TROP2-targeted ADCs into TNBC care? This expert-led recording from a series of national visiting lecture series updates clinicians on ...
Rush University Medical Center

Checkpoint Blockade in the Adjuvant and Neoadjuvant Settings: Key Considerations for the Surgical Oncologist

A multidisciplinary panel of faculty discuss the use of neoadjuvant and adjuvant immunotherapy for esophageal and gastric cancers in this recorded virtual tumor board. Throughout the case discussions, faculty discuss how to properly incorporate immunotherapies into care plans based on the latest clinical trial data and recommendations. The faculty also highlight the role of biomarkers in identifying eligible patients and ongoing clinical trials that will further impact the use of immunotherapi...
Society of Surgical Oncology (SSO)

Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma

This immersive practice guide offers a “how to” method for introducing day-to-day strategies in the real world through data, guidelines, and decision-making recommendations. Expert faculty address which approaches may not be working, complexities in managing this patient population, insights on how the latest evidence supports a practical recommendation and review available therapies to optimize treatment selection. The prevalence of MM is higher in some racial/ethnic minorities and the...
ACHL

CSU: An Older African American Adult Male With Widespread, Persistent Pruritus

Target Audience The target audience will be comprised of allergists, dermatologists, specialty nurse practitioners, specialty physician assistants, and managed care/pharmacy directors. Program Overview Chronic spontaneous urticaria (CSU) is a chronic immune-mediated condition characterized by sudden development of wheals and/or angioedema, as well as presenting with significant debilitation and considerable burden on patients’ quality of life. The diagnosis and management of CSU is comp...
Relias LLC

Right Treatment, Right Time: A Comprehensive Curriculum on Individualized Treatment Approaches for Multiple Sclerosis

Target Audience This activity is designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS. Program Overview This timely live webinar provides an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies. Our distinguished faculty also discuss sequencing considerations, including vaccines, that can impact the c...
The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education.

Late-breaking Science with DOACs and Implications for Patient Care

Hear from Christian Ruff, MD, MPH on the latest clinical trial data related to DOACs and implications for patient care. This expert perspective provides clinicians with practical insights to apply to their practice. Dr. Ruff discusses the most recent evidence with DOACs across a multitude of disease states, including acute venous thromboembolism in patients with elevated BMI, peripheral artery disease, and COVID-19. Exciting new evidence with the novel factor XIa drug class is also covered.
ACHL

Improving CLL Point-of-Care Decisions Utilizing BTK Inhibitors: Aligning Patient and Provider Goals

Target Audience The intended audience for this activity are hematologic oncologists, hematologists, oncology advanced practice providers (NPs and PAs), oncology nurses, and other clinicians involved in the management of patients with CLL. Learning Objectives Upon completion of this activity, participants should be better able to: Review patient-specific criteria that determine eligibility for first-line and subsequent CLL therapies List the emerging combination regimens, including...
Postgraduate Institute for Medicine and PlatformQ Health Education, LLC, working in collaboration with the CLL Society (CLLS) and the Leukemia & Lymphoma Society (LLS).

Improving CLL Point-of-Care Decisions Utilizing BTK Inhibitors: Emerging Combinations for Newly Diagnosed CLL High-Risk Relapsed/Refractory (R/R) CLL

Target Audience The intended audience for this activity are hematologic oncologists, hematologists, oncology advanced practice providers (NPs and PAs), oncology nurses, and other clinicians involved in the management of patients with CLL. Learning Objectives Upon completion of this activity, participants should be better able to: Review patient-specific criteria that determine eligibility for first-line and subsequent CLL therapies List the emerging combination regimens, including BTK inhi...
Postgraduate Institute for Medicine and PlatformQ Health Education, LLC,

ENHANCING DRAVET SYNDROME OUTCOMES: STRATEGIES FOR EARLY DIAGNOSIS AND COMPREHENSIVE MANAGEMENT

TARGET AUDIENCE The educational design of this activity addresses the needs of neurologists, pediatric neurologists, epileptologists, pediatric epileptologists, pediatricians, primary care providers, general practitioners, nurses, nurse practitioners, physician assistants, and pharmacists involved and/or interested in the management of patients with DS. STATEMENT OF NEED/PROGRAM OVERVIEW Despite the importance of early diagnosis, Dravet syndrome (DS) is often misdiagnosed in children an...
Global Education Group and PlatformQ Health Education, LLC, in collaboration with the Dravet Syndrome Foundation and the National Organization for Rare Disorders, Inc.

Data-Driven Decisions in Crohn's Disease: Positioning Patients for Success

While there is a tendency for clinicians to rely on one approach to treating Crohn's disease (CD), making confident data-driven treatment decisions in moderate-to-severe CD is imperative for durable, long-term remission. The traditional approach that has been based on progressive, step-wise treatment intensification with re-evaluation of response according to symptoms does not improve long-term outcomes in CD and increases risk for bowel damage. However, the introduction of treat-to-target (T2...
CME Outfitters

A Clinical Compendium on HIV Treatment Selection: Real Cases, Real Challenges, Real Solutions

TARGET AUDIENCE: This activity is designed to meet the educational needs of HIV specialists, infectious disease specialists, primary care physicians, nurse practitioners, nurses, and other healthcare professionals who care for persons living with HIV. PROGRAM OVERVIEW: In this activity, Drs. Melissa Badowski and James Sosman will review 4 case studies inspired by real-world challenges encountered in routine clinical practice. Their discussions delve into recent clinical advances in the use ...
The Annenberg Center for Health Sciences at Eisenhower

Lipids Health Prime Time™: Episode 2 Expert Opinions on the Role of Nonstatin Therapies: Exploring the Evidence for New and Emerging Nonstatin Options

TARGET AUDIENCE: This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs. PROGRAM OVERVIEW: This fast-paced news broadcast features expert discussions about incorporating new and emerging nonstatin therapies for the lowering of low-density lipoprotein cholesterol (LDL-C) into clinical practice. LEARNING OBJECTIVES: At the conc...
National Lipid Association. Paradigm Medical Communications, LLC is the educational partner

Tryptase Testing in Chronic Mast Cell Disorders and Acute Settings

Are you familiar with the role of serum tryptase testing in diagnosing idiopathic anaphylaxis and mastocytosis? What role does serum tryptase play in the ongoing management of patients who have anaphylactic reactions to insect venom, and are there different considerations when a patient has a known trigger? Expert faculty Dr. Phil Lieberman shares his insights on serum tryptase testing in clinical practice and its importance in assessing mast cell disorders and anaphylaxis. This moderated disc...
ACHL

PFF Summit Highlights: News You Can Use

Across three brief videos, expert faculty Dr. Joseph Lasky discusses highlights and data from the PFF Summit 2021, which took place virtually. Dr. Lasky provides insights into updated diagnostic guidance, emerging therapies, and patient perspectives across the spectrum of interstitial lung diseases (ILD). Don’t miss this opportunity to hear the latest research in ILD! A differential diagnosis of ILD can be challenging and patients often experience delays, but an accurate diagnosis is nece...
ACHL

Community Practice Connections™: Alpha-1 Antitrypsin Deficiency—Strategies to Optimize Screening, Diagnosis, and Management

Target Audience This educational program is directed toward pulmonologists, primary care providers, allergists, nurse practitioners, physician assistants, nurses, and other health care professionals involved in the care of patients with AATD. Learning Objectives Upon successful completion of this activity, you should be better prepared to: • Describe the genetic etiology and pathophysiology of AATD • Perform diagnosis of patients with suspected AATD using recommended laboratory tests ...
Physicians’ Education Resource

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map